Related Experiment Video
Updated: Sep 14, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Stroke Treatment in the Era of COVID-19: a Review
Marialaura Simonetto1,2, Paul M Wechsler1,2, Alexander E Merkler1,2
1Department of Neurology, Weill Cornell Medicine, New York Presbyterian Hospital, Room F610, 525 East 68th Street, New York, NY 10065 USA.
Insights
The COVID-19 pandemic increases stroke risk, including ischemic stroke and other cerebrovascular events. However, pandemic-driven improvements in stroke care systems may offer long-term benefits for patients.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- COVID-19 is linked to various neurological complications, notably cerebrovascular diseases.
- The pandemic has significantly impacted healthcare systems and patient care pathways.
Purpose of the Study:
- To conduct a comprehensive review of stroke epidemiology, pathophysiology, and treatment during the COVID-19 pandemic.
- To analyze the impact of COVID-19 on stroke systems of care.
Main Methods:
- Literature review and synthesis of existing studies on COVID-19 and stroke.
- Analysis of epidemiological data, pathophysiological mechanisms, and treatment strategies.
- Evaluation of changes in stroke care delivery during the pandemic.
Main Results:
- COVID-19 is associated with an elevated risk of various stroke types, including ischemic stroke, intracranial hemorrhage, and cerebral venous sinus thrombosis.
- The pandemic has altered stroke systems of care, necessitating adaptations in diagnosis and management.
- Despite challenges, the pandemic has spurred innovations in stroke care delivery.
Conclusions:
- COVID-19 presents a significant risk factor for stroke, demanding continued vigilance and research.
- Adaptations in stroke care systems during the pandemic may lead to improved long-term outcomes.
- Understanding the interplay between COVID-19 and cerebrovascular disease is crucial for future public health strategies.
Purpose Of Review:
To describe a comprehensive review of the epidemiology, pathophysiology, and treatment of stroke in the era of COVID-19.
Recent Findings:
COVID-19 is associated with myriad neurological disorders, including cerebrovascular disease. While ischemic stroke is the most common, COVID-19 is associated with an increased risk of intracranial hemorrhage, arterial dissection, posterior reversible encephalopathy syndrome, and cerebral venous sinus thrombosis. In this review, we discuss the epidemiology, pathophysiology, and treatment of stroke due to COVID-19. In addition, we describe how COVID-19 has changed the landscape of stroke systems of care and the effect this has had on patients with cerebrovascular disease.
Summary:
While COVID-19 is associated with a heightened risk of stroke, the pandemic has led to advances in stroke systems of care that may reduce the long-term burden of stroke.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Electroconvulsive Therapy